Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-Infection

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Elzi, Luigia ^a   Steffen, Ingrid ^b   Furrer, Hansjakob ^c   Fehr, Jan ^d   Cavassini, Matthias ^e   Hirschel, Bernard ^f   Hoffmann, Matthias ^g   Bernasconi, Enos ^h   Bassetti, Stefano ⁱ   Battegay, Manuel ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^g CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^h REGIONAL HOSPITAL OF LUGANO   (Switzerland)

ⁱ KANTONSSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; MALE; MIXED INFECTION; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS; COHORT ANALYSIS; DIAGNOSTIC PROCEDURES; EVALUATION; IMMUNOLOGY; LATENT TUBERCULOSIS; METHODOLOGY; MYCOBACTERIUM TUBERCULOSIS; SWITZERLAND;

ADULT; CLINICAL LABORATORY TECHNIQUES; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; SWITZERLAND; TUBERCULIN TEST;

EID: 81055149774     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-319     Document Type: Article

References (40)

1. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003, 163(9):1009-1021. 10.1001/archinte.163.9.1009, 12742798.
2. Dye C. Global epidemiology of tuberculosis. Lancet 2006, 367(9514):938-940. 10.1016/S0140-6736(06)68384-0, 16546542.
3. Havlir DV, Barnes PF. Tuberculosis in patients with human immunodeficiency virus infection. The New England journal of medicine 1999, 340(5):367-373. 10.1056/NEJM199902043400507, 9929528.
4. Perneger TV, Sudre P, Lundgren JD, Hirschel B. Does the onset of tuberculosis in AIDS predict shorter survival? Results of a cohort study in 17 European countries over 13 years. AIDS in Europe Study Group. BMJ (Clinical research ed 1995, 311(7018):1468-1471.
5. Horsburgh CR. Priorities for the treatment of latent tuberculosis infection in the United States. The New England journal of medicine 2004, 350(20):2060-2067. 10.1056/NEJMsa031667, 15141044.
6. Bailey WC, Gerald LB, Kimerling ME, Redden D, Brook N, Bruce F, Tang S, Duncan S, Brooks CM, Dunlap NE. Predictive model to identify positive tuberculosis skin test results during contact investigations. Jama 2002, 287(8):996-1002. 10.1001/jama.287.8.996, 11866647.
7. Huebner RE, Schein MF, Bass JB. The tuberculin skin test. Clin Infect Dis 1993, 17(6):968-975. 10.1093/clinids/17.6.968, 8110954.
8. Slovis BS, Plitman JD, Haas DW. The case against anergy testing as a routine adjunct to tuberculin skin testing. JAMA 2000, 283(15):2003-2007. 10.1001/jama.283.15.2003, 10789669.
9. Elzi L, Schlegel M, Weber R, Hirschel B, Cavassini M, Schmid P, Bernasconi E, Rickenbach M, Furrer H. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clin Infect Dis 2007, 44(1):94-102. 10.1086/510080, 17143823.
10. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008, 149(3):177-184. 2951987, 18593687.
11. Chapman AL, Munkanta M, Wilkinson KA, Pathan AA, Ewer K, Ayles H, Reece WH, Mwinga A, Godfrey-Faussett P, Lalvani A. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS (London, England) 2002, 16(17):2285-2293.
12. Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, Shigeto E, Harada N, Mitarai S, Okada M, et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004, 170(1):59-64. 10.1164/rccm.200402-179OC, 15059788.
13. Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 2004, 364(9452):2196-2203. 10.1016/S0140-6736(04)17592-2, 15610806.
14. Seshadri C, Uiso LO, Ostermann J, Diefenthal H, Shao HJ, Chu HY, Asmuth DM, Thielman NM, Bartlett JA, Crump JA. Low sensitivity of T-cell based detection of tuberculosis among HIV co-infected Tanzanian in-patients. East Afr Med J 2008, 85(9):442-449. 3168735, 19537417.
15. Goletti D, Raja A, Syed Ahamed Kabeer B, Rodrigues C, Sodha A, Carrara S, Vernet G, Longuet C, Ippolito G, Thangaraj S, et al. Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?. PLoS ONE 2010, 5(9):e12577. 10.1371/journal.pone.0012577, 2935361, 20830287.
16. CDC Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection. MMWR 59(RR-5):1-26. CDC.
17. T-SPOT Oxford Immunotec. Oxford UK, Accessed 12 September 2010., http://www.oxfordimmunotec.com
18. Rangaka MX, Wilkinson KA, Seldon R, Van Cutsem G, Meintjes GA, Morroni C, Mouton P, Diwakar L, Connell TG, Maartens G, et al. Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection. American journal of respiratory and critical care medicine 2007, 175(5):514-520.
19. Mazurek GH, Jereb J, Vernon A, Lobue P, Goldberg S, Castro K. Uldated guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2010, 59(RR-5):1-25.
20. Schoeni-Affolter F, Ledergerber B, Rickenbach M, Rudin C, Guenthard HF, Telenti A, Furrer H, Yerly S, PF. Cohort profile: the Swiss HIV Cohort study. Int J Epidemiol 2010, 39(5):1179-1189.
21. CDC 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR, 1992(41). 1992, CDC.
22. World Health Organisation, Geneva The International Classification of Diseases and Related Health Problems, 10th revision (ICD10). World Health Organisation, Geneva., http://www.who.int/classifications/apps/icd/icd10online/
23. Gasser O, Bihl FK, Wolbers M, Loggi E, Steffen I, Hirsch HH, Gunthard HF, Walker BD, Brander C, Battegay M, et al. HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts. PLoS Med 2007, 4(3):e96. 10.1371/journal.pmed.0040096, 1831733, 17388662.
24. Khanna N, Wolbers M, Mueller NJ, Garzoni C, Du Pasquier RA, Fux CA, Vernazza P, Bernasconi E, Viscidi R, Battegay M, et al. JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy. J Virol 2009, 83(9):4404-4411. 10.1128/JVI.02657-08, 2668450, 19211737.
25. Rohrbach J, Robinson N, Harcourt G, Hammond E, Gaudieri S, Gorgievski M, Telenti A, Keiser O, Gunthard HF, Hirschel B, et al. Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy. Gut 2010, 59(9):1252-1258. 10.1136/gut.2009.205971, 20660698.
26. Balcells ME, Perez CM, Chanqueo L, Lasso M, Villanueva M, Espinoza M, Villarroel L, Garcia P. A comparative study of two different methods for the detection of latent tuberculosis in HIV-positive individuals in Chile. Int J Infect Dis 2008, 12(6):645-652. 10.1016/j.ijid.2008.03.005, 18534887.
27. Jones S, de Gijsel D, Wallach FR, Gurtman AC, Shi Q, Sacks H. Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals. Int J Tuberc Lung Dis 2007, 11(11):1190-1195.
28. Luetkemeyer AF, Charlebois ED, Flores LL, Bangsberg DR, Deeks SG, Martin JN, Havlir DV. Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. American journal of respiratory and critical care medicine 2007, 175(7):737-742. 10.1164/rccm.200608-1088OC, 1899289, 17218620.
29. Ruhwald M, Dominguez J, Latorre I, Losi M, Richeldi L, Pasticci MB, Mazzolla R, Goletti D, Butera O, Bruchfeld J, et al. A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. Tuberculosis (Edinb) 2011, 91(3):260-267.
30. Raby E, Moyo M, Devendra A, Banda J, De Haas P, Ayles H, Godfrey-Faussett P. The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis. PLoS ONE 2008, 3(6):e2489. 10.1371/journal.pone.0002489, 2409073, 18560573.
31. Stephan C, Wolf T, Goetsch U, Bellinger O, Nisius G, Oremek G, Rakus Z, Gottschalk R, Stark S, Brodt HR, et al. Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country. AIDS (London, England) 2008, 22(18):2471-2479.
32. Aabye MG, Ravn P, PrayGod G, Jeremiah K, Mugomela A, Jepsen M, Faurholt D, Range N, Friis H, Changalucha J, et al. The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS ONE 2009, 4(1):e4220. 10.1371/journal.pone.0004220, 2626632, 19156218.
33. Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, Ravn P. Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respiratory research 2006, 7:56. 10.1186/1465-9921-7-56, 1523341, 16579856.
34. Richeldi L, Losi M, D'Amico R, Luppi M, Ferrari A, Mussini C, Codeluppi M, Cocchi S, Prati F, Paci V, et al. Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest 2009, 136(1):198-204. 10.1378/chest.08-2575, 19318676.
35. Vincenti D, Carrara S, Butera O, Bizzoni F, Casetti R, Girardi E, Goletti D. Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study. Clinical and experimental immunology 2007, 150(1):91-98. 10.1111/j.1365-2249.2007.03462.x, 2219274, 17680823.
36. Oni T, Patel J, Gideon HP, Seldon R, Wood K, Hlombe Y, Wilkinson KA, Rangaka MX, Mendelson M, Wilkinson RJ. Enhanced diagnosis of HIV-1 associated tuberculosis by relating T-SPOT.TB and CD4 counts. Eur Respir J 2010,
37. Karam F, Mbow F, Fletcher H, Senghor CS, Coulibaly KD, LeFevre AM, Ngom Gueye NF, Dieye T, Sow PS, Mboup S, et al. Sensitivity of IFN-gamma release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression. PLoS ONE 2008, 3(1):e1441. 10.1371/journal.pone.0001441, 2174527, 18197251.
38. Talati NJ, Seybold U, Humphrey B, Aina A, Tapia J, Weinfurter P, Albalak R, Blumberg HM. Poor concordance between interferon-gamma release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals. BMC infectious diseases 2009, 9:15. 10.1186/1471-2334-9-15, 2649136, 19208218.
39. Mandalakas AM, Hesseling AC, Chegou NN, Kirchner HL, Zhu X, Marais BJ, Black GF, Beyers N, Walzl G. High level of discordant IGRA results in HIV-infected adults and children. Int J Tuberc Lung Dis 2008, 12(4):417-423.
40. Ferrara G, Losi M, D'Amico R, Roversi P, Piro R, Meacci M, Meccugni B, Dori IM, Andreani A, Bergamini BM, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006, 367(9519):1328-1334. 10.1016/S0140-6736(06)68579-6, 16631911.